Alginate-coated chitosan nanoparticles protect protein drugs from acid degradation in gastric media

Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100:5–28. https://doi.org/10.1016/j.jconrel.2004.08.010 Al-Tahami K, Singh J (2007) Smart polymer based delivery systems for peptides and proteins. Recent Pat Drug Deliv Formul 1:65–71. https://doi.org/10.2174/187221107779814113 Amidi M, Mastrobattista E, Jiskoot W, Hennink WE (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62:59–82. https://doi.org/10.1016/j.addr.2009.11.009 Bagre AP, Jain K, Jain NK (2013) Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int J Pharm 456:31–40. https://doi.org/10.1016/j.ijpharm.2013.08.037 Berthold A, Cremer K, Kreuter J (1996) Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release 39:17–25. https://doi.org/10.1016/0168-3659(95)00129-8 Bronze-Uhle E, Costa BC, Ximenes VF, Lisboa-Filho PN (2016) Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl 10:11–21. https://doi.org/10.2147/NSA.S117018 Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63:125–132. https://doi.org/10.1002/(SICI)1097-4628(19970103)63:1%3c125::AID-APP13%3e3.0.CO;2-4 Coppi G, Iannuccelli V, Leo E et al (2001) Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm 27:393–400. https://doi.org/10.1081/DDC-100104314 Cui Z, Mumper RJ (2001) Chitosan-based nanoparticles for topical genetic immunization. J Control Release 75:409–419. https://doi.org/10.1016/S0168-3659(01)00407-2 Fan W, Yan W, Xu Z, Ni H (2012) Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surfaces B Biointerfaces 90:21–27. https://doi.org/10.1016/j.colsurfb.2011.09.042 Fan YF, Wang YN, Fan YG, Ma J (2006) Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int J Pharm 324:158–167. https://doi.org/10.1016/j.ijpharm.2006.05.062 Ferreira Tomaz A, Sobral de Carvalho S, Cardoso Barbosa R et al (2018) Ionically crosslinked chitosan membranes used as drug carriers for cancer therapy application. Materials (basel) 11:2051. https://doi.org/10.3390/ma11102051 Frokjaer S, Otzen DE (2005) Protein drug stability: a formulation challenge. Nat Rev Drug Discov 4:298–306. https://doi.org/10.1038/nrd1695 Gan Q, Wang T, Cochrane C, McCarron P (2005) Modulation of surface charge, particle size and morphological properties of chitosan–TPP nanoparticles intended for gene delivery. Colloids Surfaces B Biointerfaces 44:65–73. https://doi.org/10.1016/j.colsurfb.2005.06.001 Ghormade V, Deshpande MV, Paknikar KM (2011) Perspectives for nano-biotechnology enabled protection and nutrition of plants. Biotechnol Adv 29:792–803. https://doi.org/10.1016/j.biotechadv.2011.06.007 Illum L, Jabbal-Gill I, Hinchcliffe M et al (2001) Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 51:81–96. https://doi.org/10.1016/S0169-409X(01)00171-5 ISO-10993-5 (2009) Biological evaluation of medical devices-Part 5: Tests for in vitro cytotoxicity Jain S, Rathi VV, Jain AK et al (2012) Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine (lond) 7:1311–1337. https://doi.org/10.2217/nnm.12.31 Katuwavila NP, Perera ADLC, Samarakoon SR et al (2016) Chitosan-alginate nanoparticle system efficiently delivers doxorubicin to MCF-7 cells. J Nanomater 2016:1–12. https://doi.org/10.1155/2016/3178904 Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surfaces B Biointerfaces 75:1–18. https://doi.org/10.1016/j.colsurfb.2009.09.001 Kurz D, Ciulla T (2002) Novel approaches for retinal drug delivery. Ophthalmol Clin North Am 15:405–410. https://doi.org/10.1016/S0896-1549(02)00034-2 Lee B-J, Min G-H (1996) Oral controlled release of melatonin using polymer-reinforced and coated alginate beads. Int J Pharm 144:37–46. https://doi.org/10.1016/S0378-5173(96)04723-0 Li T, Shi X-W, Du Y-M, Tang Y-F (2007) Quaternized chitosan/alginate nanoparticles for protein delivery. J Biomed Mater Res Part A 83A:383–390. https://doi.org/10.1002/jbm.a.31322 Li X, Kong X, Shi S et al (2008) Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol 8:89. https://doi.org/10.1186/1472-6750-8-89 Loutfy SA, Alam El-Din HM, Elberry MH et al (2016) Synthesis, characterization and cytotoxic evaluation of chitosan nanoparticles: in vitro liver cancer model. Adv Nat Sci Nanosci Nanotechnol 7:035008. https://doi.org/10.1088/2043-6262/7/3/035008 Mohanraj VJ, Barnes TJ, Prestidge CA (2010) Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins. Int J Pharm 392:285–293. https://doi.org/10.1016/j.ijpharm.2010.03.061 Mueller EA, Kovarik JM, van Bree JB et al (1994) Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 11:301–304. https://doi.org/10.1023/a:1018923912135 Muheem A, Shakeel F, Jahangir MA et al (2016) A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm J 24:413–428. https://doi.org/10.1016/j.jsps.2014.06.004 Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 50:161–177. https://doi.org/10.1016/s0939-6411(00)00087-4 Nayar S, Mir A, Ashok A et al (2010) Bovine serum albumin binding and drug delivery studies with PVA-ferrofluid. J Bionic Eng 7:29–34. https://doi.org/10.1016/S1672-6529(09)60188-8 Okada E, Sasaki S, Ishii N et al (1997) Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 159:3638–3647 Othayoth R, Mathi P, Bheemanapally K et al (2015) Characterization of vitamin–cisplatin-loaded chitosan nano-particles for chemoprevention and cancer fatigue. J Microencapsul 32:578–588. https://doi.org/10.3109/02652048.2015.1065921 Park JH, Saravanakumar G, Kim K, Kwon IC (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 62:28–41. https://doi.org/10.1016/j.addr.2009.10.003 Park K, Kwon IC, Park K (2011) Oral protein delivery: current status and future prospect. React Funct Polym 71:280–287. https://doi.org/10.1016/j.reactfunctpolym.2010.10.002 Patil S, Narvekar A, Puranik A et al (2019) Formulation of therapeutic proteins: strategies for developing oral protein formulations. In: Bachhav Y (ed) Innovative dosage forms: design and development at early stage. Wiley, Hoboken, pp 391–432 Raj L, Jonisha R, Revathi B, Jayalakshmy E (2015) Preparation and characterization of BSA and chitosan nanopartices for sustainable delivery system for quercetin. J Appl Pharm Sci. https://doi.org/10.7324/JAPS.2015.50701 Retnakumari A, Setua S, Menon D et al (2010) Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Nanotechnology 21:055103. https://doi.org/10.1088/0957-4484/21/5/055103 Safdar R, Omar AA, Arunagiri A et al (2019) Potential of chitosan and its derivatives for controlled drug release applications—a review. J Drug Deliv Sci Technol 49:642–659. https://doi.org/10.1016/j.jddst.2018.10.020 Sahu SK, Prusty AK (2010) Design and evaluation of a nanoparticulate system prepared by biodegradable polymers for oral administration of protein drugs. Pharmazie 65:824–829 Sarmento B, Martins S, Ferreira D, Souto EB (2007) Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed 2:743–749 Shu X, Zhu K (2002) Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int J Pharm 233:217–225. https://doi.org/10.1016/S0378-5173(01)00943-7 Sinha V, Singla A, Wadhawan S et al (2004) Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1–33. https://doi.org/10.1016/j.ijpharm.2003.12.026 Su F-Y, Lin K-J, Sonaje K et al (2012) Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials 33:2801–2811. https://doi.org/10.1016/j.biomaterials.2011.12.038 Takka S, Gürel A (2010) Evaluation of chitosan/alginate beads using experimental design: formulation and in vitro characterization. AAPS PharmSciTech 11:460–466. https://doi.org/10.1208/s12249-010-9406-z Torchilin VP, Lukyanov AN (2003) Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 8:259–266. https://doi.org/10.1016/S1359-6446(03)02623-0 Tran P, Park J-S (2021) Formulation of solid dispersion to improve dissolution and oral bioavailability of poorly soluble dexibuprofen. Pharm Dev Technol 26:422–430. https://doi.org/10.1080/10837450.2021.1884259 Wang L-Y, Ma G-H, Su Z-G (2005) Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug. J Control Release 106:62–75. https://doi.org/10.1016/j.jconrel.2005.04.005 Zohri M, Nomani A, Gazori T et al (2011) Characterization of chitosan/alginate self-assembled nanoparticles as a protein carrier. J Dispers Sci Technol 32:576–582. https://doi.org/10.1080/01932691003757314